You are here: Industry Insights > COVID-19

News List

FDA COVID-19 Update contractpharma
April 28, 2020
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine.
Romark Initiates Trials of NT-300 for COVID-19 Prevention contractpharma
April 28, 2020
In cell cultures, the active ingredient in NT-300, nitazoxanide, inhibits replication of a broad range of respiratory viruses, including SARS-CoV-2.
CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19 contractpharma
April 28, 2020
Will compare pacritinib plus standard of care versus placebo plus standard of care in 358 patients with severe COVID-19.
Global Cord Blood Corporation Provides Further Update on COVID-19 prnasia
April 27, 2020
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 201
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19 prnasia
April 27, 2020
Menarini Silicon Biosystems, a global leader in liquid biopsy and rare cells technologies, today announces that it is exploring the possible use of its proprietary CELLSEARCH technology to study the progression of COVID-19 disease --and to potentially ide
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.
Herbal products from CIMAP may boost immunity to fight COVID-19 infection expresspharma
April 27, 2020
It has decided to transfer the technology of its herbal products, CIM-Paushak and Herbal Cough Syrup to entrepreneurs and start-up companies.
Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients pharmaceutical-business-review
April 26, 2020
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
Hope Biosciences announces third FDA-approved clinical trial for COVID-19 pharmaceutical-business-review
April 26, 2020
Hope Biosciences announces FDA approval on their third clinical trial for COVID-19.This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics.
Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments worldpharmanews
April 26, 2020
Bayer announced its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page